VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Return
12.28%
This Quarter Return
-7.05%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.34B
AUM Growth
+$132M
(+11%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
17.84%
Top 10 Holdings %
Top 10 Hldgs %
54.87%
Holding
79
New
21
Increased
28
Reduced
5
Closed
19
Top Buys
| 1 |
Ultragenyx Pharmaceutical
RARE
|
$69.5M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$42.7M |
| 3 |
Exact Sciences
EXAS
|
$34.9M |
| 4 |
Arcellx
ACLX
|
$31.7M |
| 5 |
Ascendis Pharma
ASND
|
$30.7M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$97.9M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$52.3M |
| 3 |
AstraZeneca
AZN
|
$27.1M |
| 4 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$21.7M |
| 5 |
argenx
ARGX
|
$19.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
TG Therapeutics
TGTX
$5.06B
| – | – |
-1,050,000
| Closed | -$16M |
|
77
Viking Therapeutics
VKTX
$2.98B
| – | – |
-75,000
| Closed | -$6.15M |
|
|
SWAV
78
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-25,000
| Closed | -$8.14M |
|
|
ALPN
79
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-350,000
| Closed | -$13.9M |
|